Core Scientific (CORZ) Enterprise Value (2021 - 2026)

Core Scientific (CORZ) has 6 years of Enterprise Value data on file, last reported at -$1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 52.49% year-over-year to -$1.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.1 billion (down 52.49% YoY), and the FY2025 full-year result was -$311.4 million, up 62.8% from the prior year.
• Enterprise Value fell to -$1.1 billion in Q1 2026, from -$311.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$52.2 million in Q4 2022 to a low of -$1.1 billion in Q1 2026.
• A 5-year average of -$325.9 million and a median of -$253.8 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 18181.06% in 2022 and surged 81.55% in 2023, its largest moves.
• Tracing CORZ's Enterprise Value over 5 years: stood at -$52.2 million in 2022, then plunged by 33.44% to -$69.7 million in 2023, then tumbled by 1100.68% to -$837.0 million in 2024, then jumped by 62.8% to -$311.4 million in 2025, then plunged by 242.15% to -$1.1 billion in 2026.
• Business Quant data shows CORZ's Enterprise Value at -$1.1 billion in Q1 2026, -$311.4 million in Q4 2025, and -$453.4 million in Q3 2025.